162 related items for PubMed ID: 36704589
1. Effectiveness of a Low Dose Prednisolone Regimen for Treatment of Relapses in Children with Steroid Sensitive Nephrotic Syndrome.
Mantan M, Kansal A, Swarnim S.
Indian J Nephrol; 2022; 32(6):588-594. PubMed ID: 36704589
[Abstract] [Full Text] [Related]
2. Sixteen-week versus standard eight-week prednisolone therapy for childhood nephrotic syndrome: the PREDNOS RCT.
Webb NJ, Woolley RL, Lambe T, Frew E, Brettell EA, Barsoum EN, Trompeter RS, Cummins C, Wheatley K, Ives NJ.
Health Technol Assess; 2019 May; 23(26):1-108. PubMed ID: 31156083
[Abstract] [Full Text] [Related]
3. Daily low-dose prednisolone to prevent relapse of steroid-sensitive nephrotic syndrome in children with an upper respiratory tract infection: PREDNOS2 RCT.
Christian MT, Webb NJ, Woolley RL, Afentou N, Mehta S, Frew E, Brettell EA, Khan AR, Milford DV, Bockenhauer D, Saleem MA, Hall AS, Koziell A, Maxwell H, Hegde S, Finlay ER, Gilbert RD, Jones C, McKeever K, Cook W, Ives N.
Health Technol Assess; 2022 Jan; 26(3):1-94. PubMed ID: 35060851
[Abstract] [Full Text] [Related]
4. Low-dose versus conventional-dose prednisolone for nephrotic syndrome relapses: a randomized controlled non-inferiority trial.
Sheikh S, Mishra K, Kumar M.
Pediatr Nephrol; 2021 Oct; 36(10):3143-3150. PubMed ID: 33861375
[Abstract] [Full Text] [Related]
5. Short-Duration Prednisolone in Children with Nephrotic Syndrome Relapse: A Noninferiority Randomized Controlled Trial.
Kainth D, Hari P, Sinha A, Pandey S, Bagga A.
Clin J Am Soc Nephrol; 2021 Feb 08; 16(2):225-232. PubMed ID: 33478976
[Abstract] [Full Text] [Related]
6. Efficacy of low-dose daily versus alternate-day prednisolone in frequently relapsing nephrotic syndrome: an open-label randomized controlled trial.
Yadav M, Sinha A, Khandelwal P, Hari P, Bagga A.
Pediatr Nephrol; 2019 May 08; 34(5):829-835. PubMed ID: 30194663
[Abstract] [Full Text] [Related]
7. Use of a low-dose prednisolone regimen to treat a relapse of steroid-sensitive nephrotic syndrome in children.
Raja K, Parikh A, Webb H, Hothi D.
Pediatr Nephrol; 2017 Jan 08; 32(1):99-105. PubMed ID: 27677978
[Abstract] [Full Text] [Related]
8. Study protocol: high-dose mizoribine with prednisolone therapy in short-term relapsing steroid-sensitive nephrotic syndrome to prevent frequent relapse (JSKDC05 trial).
Hama T, Nakanishi K, Ishikura K, Ito S, Nakamura H, Sako M, Saito-Oba M, Nozu K, Shima Y, Iijima K, Yoshikawa N, Japanese Study Group of Kidney Disease in Children (JSKDC).
BMC Nephrol; 2018 Sep 10; 19(1):223. PubMed ID: 30200895
[Abstract] [Full Text] [Related]
9. Single vs split dose of prednisolone in the treatment of relapses of childhood nephrotic syndrome.
Weerasooriya WALK, Abeyagunawardena AS, Thalgahagoda RS.
Eur J Pediatr; 2023 Apr 10; 182(4):1741-1747. PubMed ID: 36757496
[Abstract] [Full Text] [Related]
10. Long term tapering versus standard prednisolone treatment for first episode of childhood nephrotic syndrome: phase III randomised controlled trial and economic evaluation.
Webb NJA, Woolley RL, Lambe T, Frew E, Brettell EA, Barsoum EN, Trompeter RS, Cummins C, Deeks JJ, Wheatley K, Ives NJ, PREDNOS Collaborative Group.
BMJ; 2019 May 23; 365():l1800. PubMed ID: 31335316
[Abstract] [Full Text] [Related]
11. Corticosteroid therapy for nephrotic syndrome in children.
Hahn D, Samuel SM, Willis NS, Craig JC, Hobson EM.
Cochrane Database Syst Rev; 2020 Aug 31; 2020(8):CD001533. PubMed ID: 35659203
[Abstract] [Full Text] [Related]
12. Evaluation of Daily Low-Dose Prednisolone During Upper Respiratory Tract Infection to Prevent Relapse in Children With Relapsing Steroid-Sensitive Nephrotic Syndrome: The PREDNOS 2 Randomized Clinical Trial.
Christian MT, Webb NJA, Mehta S, Woolley RL, Afentou N, Frew E, Brettell EA, Khan AR, Milford DV, Bockenhauer D, Saleem MA, Hall AS, Koziell A, Maxwell H, Hegde S, Prajapati H, Gilbert RD, Jones C, McKeever K, Cook W, Ives N.
JAMA Pediatr; 2022 Mar 01; 176(3):236-243. PubMed ID: 34928294
[Abstract] [Full Text] [Related]
13. Extending initial prednisolone treatment in a randomized control trial from 3 to 6 months did not significantly influence the course of illness in children with steroid-sensitive nephrotic syndrome.
Sinha A, Saha A, Kumar M, Sharma S, Afzal K, Mehta A, Kalaivani M, Hari P, Bagga A.
Kidney Int; 2015 Jan 01; 87(1):217-24. PubMed ID: 25029428
[Abstract] [Full Text] [Related]
14. Single- versus divided-dose prednisolone therapy for relapses of nephrotic syndrome.
Ekka BK, Bagga A, Srivastava RN.
Pediatr Nephrol; 1997 Oct 01; 11(5):597-9. PubMed ID: 9323286
[Abstract] [Full Text] [Related]
15. Short courses of daily prednisolone during upper respiratory tract infections reduce relapse frequency in childhood nephrotic syndrome.
Abeyagunawardena AS, Thalgahagoda RS, Dissanayake PV, Abeyagunawardena S, Illangasekera YA, Karunadasa UI, Trompeter RS.
Pediatr Nephrol; 2017 Aug 01; 32(8):1377-1382. PubMed ID: 28341877
[Abstract] [Full Text] [Related]
16. Short course daily prednisolone therapy during an upper respiratory tract infection in children with relapsing steroid-sensitive nephrotic syndrome (PREDNOS 2): protocol for a randomised controlled trial.
Webb NJ, Frew E, Brettell EA, Milford DV, Bockenhauer D, Saleem MA, Christian M, Hall AS, Koziell A, Maxwell H, Hegde S, Finlay ER, Gilbert RD, Booth J, Jones C, McKeever K, Cook W, Ives NJ, PREDNOS 2 study group.
Trials; 2014 Apr 27; 15():147. PubMed ID: 24767719
[Abstract] [Full Text] [Related]
17. Interventions for minimal change disease in adults with nephrotic syndrome.
Azukaitis K, Palmer SC, Strippoli GF, Hodson EM.
Cochrane Database Syst Rev; 2022 Mar 01; 3(3):CD001537. PubMed ID: 35230699
[Abstract] [Full Text] [Related]
18. An open label non-inferiority randomized controlled trial evaluated alternate day prednisolone given daily during infections vs. levamisole in frequently relapsing nephrotic syndrome.
Sinha A, Devi KG, Kalra S, Mani K, Hari P, Bagga A.
Kidney Int; 2024 May 01; 105(5):1113-1123. PubMed ID: 38360110
[Abstract] [Full Text] [Related]
19. Clinico-Biochemical Profile and Identification of Independent Risk Factors of Frequent Relapse in Childhood-Onset Steroid-Sensitive Nephrotic Syndrome.
Behera MR, Kumar CM, Biswal SR, Reddy PVK, Reddy GBP, Polakampalli N, Kumar R, Sahu SK.
Cureus; 2022 Jan 01; 14(1):e21765. PubMed ID: 35251836
[Abstract] [Full Text] [Related]
20. Long-term prognosis of 4 children with steroid-sensitive nephrotic syndrome and relapse after 30 years of age.
Motoyama O, Sakai K, Iitaka K.
CEN Case Rep; 2014 May 01; 3(1):106-109. PubMed ID: 28509256
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
